Global Propofol Market Growth 2023-2029

Global Propofol Market Growth 2023-2029

The global Propofol market size is projected to grow from US$ 17 million in 2022 to US$ 22 million in 2029; it is expected to grow at a CAGR of 3.7% from 2023 to 2029.

Bachem is the world's largest manufacturers of Propofol, with a market share of nearly 50%, other major manufacturers include Curia and SI Group. Europe dominates the global propofol market with market share 60% in production, followed by China and India. In terms of product types, propofol with purity below 99.5% occupied more than 99% of the share, and the rest is propofol with purity over 99.5%. In terms of product application, propofol injection emulsion occupies for a share of 65%, and propofol mct/lct injection occupies for a share of 35%.

The Propofol API is an intravenous, short acting anesthetic with rapid onset of action used in the induction and maintenance of anesthesia.

LPI (LP Information)' newest research report, the “Propofol Industry Forecast” looks at past sales and reviews total world Propofol sales in 2022, providing a comprehensive analysis by region and market sector of projected Propofol sales for 2023 through 2029. With Propofol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Propofol industry.

This Insight Report provides a comprehensive analysis of the global Propofol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Propofol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Propofol market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Propofol and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Propofol.

This report presents a comprehensive overview, market shares, and growth opportunities of Propofol market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Purity above 99.5%
Purity below 99.5%

Segmentation by application
Propofol Injectable Emulsion
Propofol MCT/LCT Injectable Emulsion

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bachem
Curia
SI Group
Neuland Laboratories
Harman Finochem
Midas Pharma
Guangdong Jiabo Pharmaceutical
Sichuan Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Beijing Sciecure Pharmaceutical
Jiangsu Nhwa Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Propofol market?

What factors are driving Propofol market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Propofol market opportunities vary by end market size?

How does Propofol break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.